BlackRock’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Sell |
376,454
-80,745
| -18% | -$24.4K | ﹤0.01% | 4736 |
|
|
2025
Q1 | $130K | Sell |
457,199
-1,566
| -0.3% | -$446 | ﹤0.01% | 4653 |
|
|
2024
Q4 | $269K | Sell |
458,765
-76,778
| -14% | -$45K | ﹤0.01% | 4506 |
|
|
2024
Q3 | $239K | Sell |
535,543
-140,701
| -21% | -$62.8K | ﹤0.01% | 4437 |
|
|
2024
Q2 | $1.79M | Buy |
676,244
+8,966
| +1% | +$23.8K | ﹤0.01% | 3945 |
|
|
2024
Q1 | $1.83M | Buy |
667,278
+4,616
| +0.7% | +$12.6K | ﹤0.01% | 3973 |
|
|
2023
Q4 | $1.61M | Buy |
662,662
+174
| +0% | +$423 | ﹤0.01% | 4038 |
|
|
2023
Q3 | $1.34M | Sell |
662,488
-7,280
| -1% | -$14.7K | ﹤0.01% | 4085 |
|
|
2023
Q2 | $1.98M | Sell |
669,768
-1,601,690
| -71% | -$4.72M | ﹤0.01% | 3973 |
|
|
2023
Q1 | $5.68M | Sell |
2,271,458
-91,763
| -4% | -$229K | ﹤0.01% | 3499 |
|
|
2022
Q4 | $7.49M | Sell |
2,363,221
-227,868
| -9% | -$722K | ﹤0.01% | 3464 |
|
|
2022
Q3 | $7.7M | Buy |
2,591,089
+106,307
| +4% | +$316K | ﹤0.01% | 3494 |
|
|
2022
Q2 | $7.58M | Buy |
2,484,782
+69,680
| +3% | +$213K | ﹤0.01% | 3563 |
|
|
2022
Q1 | $32.6M | Sell |
2,415,102
-40,582
| -2% | -$548K | ﹤0.01% | 2803 |
|
|
2021
Q4 | $32M | Buy |
2,455,684
+446,781
| +22% | +$5.82M | ﹤0.01% | 2933 |
|
|
2021
Q3 | $18.8M | Buy |
2,008,903
+15,855
| +0.8% | +$149K | ﹤0.01% | 3260 |
|
|
2021
Q2 | $20.4M | Buy |
1,993,048
+1,002,599
| +101% | +$10.3M | ﹤0.01% | 3245 |
|
|
2021
Q1 | $18.2M | Buy |
990,449
+119,313
| +14% | +$2.2M | ﹤0.01% | 3177 |
|
|
2020
Q4 | $29.8M | Buy |
871,136
+797,152
| +1,077% | +$27.3M | ﹤0.01% | 2738 |
|
|
2020
Q3 | $1.37M | Buy |
+73,984
| New | +$1.37M | ﹤0.01% | 3916 |
|